CGL on path to prove industry-wide conspiracy rigged prices of generic drugs
August 15, 2019: CGL sustained claims of an overarching conspiracy in the generic drug market against a motion to dismiss filed by 29 generic drugmakers. CGL defeated the drugmakers’ motion by showing that their price-fixing scheme was an overlapping, interdependent conspiracy (an illegal agreement) with a common goal: to make billions of dollars by overcharging pharmacies and patients for basic generic drugs. Price fixing is a federal crime. The federal court in Philadelphia ruled that CGL had discovered enough evidence of an overarching conspiracy to sustain the theory that all the defendant drugmakers should be held jointly liable for their scheme to divvy up drug markets and increase prices.